US Broker Ratings

SIGA Technologies Inc. (SIGA): Valuation Insights and Growth Potential Amidst Healthcare Sector Challenges

Investors eyeing opportunities in the healthcare sector might find SIGA Technologies Inc. (NASDAQ: SIGA) an intriguing prospect. With a market capitalization of $481.94 million, this New..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges with an 8.08% Upside Potential

Investors examining Cross Country Healthcare, Inc. (NASDAQ: CCRN) are evaluating a company deeply rooted in the healthcare sector, specifically within the medical care facilities industry. Based..

Replimune Group, Inc. (REPL) Stock Analysis: A 59% Potential Upside in Oncolytic Immunotherapy

Investors looking to tap into the burgeoning field of biotechnology may find Replimune Group, Inc. (REPL) an intriguing prospect. This clinical-stage company, with a market cap..

Talkspace, Inc. (TALK) Investor Outlook: 25.94% Potential Upside and Strong Buy Ratings Highlight Growth Potential

Talkspace, Inc. (NASDAQ: TALK), a pioneering force in the virtual behavioral healthcare sector, is capturing the attention of investors thanks to its impressive potential upside and..

Simulations Plus, Inc. (SLP): Investor Outlook and Analyst Consensus Reveal 18.76% Upside Potential

Simulations Plus, Inc. (NASDAQ: SLP), a notable player in the Healthcare sector specializing in Health Information Services, presents a compelling case for investors seeking exposure to..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Volatility with Strategic Growth in Biotech

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market cap of $1.6 billion,..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges in the Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a promising player in the biotechnology sector, is making waves with its innovative approach to cell programming and biosecurity. Despite..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 221.90% Potential Upside in the Biotech Space

MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene therapy company, stands at an intriguing intersection of innovation and investment opportunity. With a market capitalization of $668.88..

Zenas BioPharma (ZBIO) Stock Analysis: Promising 99.75% Upside Potential for Investors

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its significant upside potential, underscored by a 99.75% potential gain based on current analyst..

STAAR Surgical Company (STAA) Investor Outlook: Assessing the 21% Potential Upside

STAAR Surgical Company (NASDAQ: STAA), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, has been a subject of significant..

Theravance Biopharma, Inc. (TBPH) Investor Outlook: Unveiling a 28.81% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) is making waves in the biotechnology sector, sporting a market capitalization of $1.05 billion. Based in South San Francisco, California, this..

Enliven Therapeutics (ELVN) Stock Analysis: A 53% Upside Potential with Strong Analyst Support

Enliven Therapeutics, Inc. (NASDAQ: ELVN) has captured the attention of investors with its promising potential, particularly in the cutting-edge field of biotechnology. As a clinical-stage biopharmaceutical..

AnaptysBio, Inc. (ANAB) Stock Analysis: Biotechnology Innovator with 43.50% Upside Potential

AnaptysBio, Inc. (ANAB), a San Diego-based biotechnology company, is making waves in the healthcare sector with its promising portfolio of immunology therapeutics. With a market capitalization..

Orthofix Medical Inc. (OFIX) Investor Outlook: Exploring a 64.86% Potential Upside in Medical Devices

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical technology sector, has caught the attention of investors with a potential upside of 64.86%, according..

Sana Biotechnology, Inc. (SANA)

⚠️ No article content returned.

..

Mind Medicine (MNMD) Stock Analysis: A Biotech Play with a 90% Potential Upside

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) presents a compelling narrative for investors interested in the biotechnology sector, particularly those focusing on innovative treatments for brain health..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Contender with 119.93% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with a promising portfolio of monoclonal antibody treatments targeting a range of critical health issues,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a 7.39% Potential Upside in Biotech Innovation

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical firm, has captured investor attention with its focus on developing innovative treatments for cystic fibrosis (CF). With a..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a Potential 37% Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for infectious diseases, has captured the interest of investors with its substantial..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 57.51% Potential Upside in the Healthcare Information Sector

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services industry, offers a compelling investment opportunity, particularly for those eyeing the healthcare sector’s..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds